• Company Information
      • About the Report
      • Documents
      • Outstanding Payments (MSME)
      • Complaints
      • Directors
      • Same Address Companies
      • Charges
      • Contact Details
      • Products & Services
      • Balance Sheet
      • Profit & Loss
      • Fund Raising
      • Shareholders & Investors
      • Board Meetings
      • Auditors

      REGALIA PHARMACEUTICAL (INDIA) PRIVATE LIMITED

      CIN: U24232PN2007PTC130885 As on: 2026-07-13
      Purchase Report

      REGALIA PHARMACEUTICAL (INDIA) PRIVATE LIMITED (CIN: U24232PN2007PTC130885) is a Private company incorporated on 20 Oct 2007. It is classified as Non-government company and is registered at Registrar of Companies, Pune. Its authorized share capital is Rs. 1000000.00 and its paid up capital is Rs. 769130.00.

      REGALIA PHARMACEUTICAL (INDIA) PRIVATE LIMITED's Annual General Meeting (AGM) was last held on 30 Sep 2022. and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 2022-03-31.REGALIA PHARMACEUTICAL (INDIA) PRIVATE LIMITED's NIC code is 2423 (which is part of its CIN). As per the NIC code, it is inolved in Manufacture of pharmaceuticals, medicinal chemicals and botanical products.

      Directors of REGALIA PHARMACEUTICAL (INDIA) PRIVATE LIMITED are ROHIT DINANATH KARPE, and ANIL POPATRAO BELKAR.

      REGALIA PHARMACEUTICAL (INDIA) PRIVATE LIMITED's Corporate Identification Number (CIN) is U24232PN2007PTC130885 and its registration number is 130885. Users may contact REGALIA PHARMACEUTICAL (INDIA) PRIVATE LIMITED on its Email address - [email protected]. Registered address of REGALIA PHARMACEUTICAL (INDIA) PRIVATE LIMITED is Lower Ground Floor 112, Akruti Sankul S N 20112059 Sadashiv Peth , PUNE, Maharashtra, India - 411030.

      Current status of REGALIA PHARMACEUTICAL (INDIA) PRIVATE LIMITED is - Active.

      Basic Information

      • CIN
      • Name
      • Listed on Stock Exchange
      • Company Status
      • ROC
      • Registration Number
      • Company Category
      • Company Sub Category
      • Class of Company
      • Date of Incorporation
      • Age of Company
      • Activity
      • Number of Members

      Annual Compliance Status

      • Date of Last Annual General Meeting
      • Date of Last Filed Balance Sheet

      Key Numbers

      • Authorised Share Capital
      • Paid-up Share Capital
      • Total Assets
      • Revenue
      • Profit
      • Salaries & Other Employee Benefit Expenses
      Want to see how this company compares within its industry or analyse broader market trends?
      Explore Prime Research for Industry & Economic Insights

      Previous Names

      Previous CINs

      ZaubaCorp's company report for REGALIA PHARMACEUTICAL (INDIA) includes audited balance sheets, profit & loss statements, charges, director history, shareholding and related-party transactions, compiled from official MCA filings — delivered as PDF and Excel.

      Purchase Report

      All companies in India are required to file various documents like financials, loan agreements, list of shareholders, details of directors, details of funding rounds and a lot more. These documents are credible and offer incredible insights about a company. However, understanding a company by viewing its documents is an extremely difficult and time consuming process.

      Our reports are designed to save you significant time by surfacing key information easily and structuring it in a way that helps in your research.

      Understanding the key findings and information in our reports can be crucial if you're a customer, vendor, investor, partner or even a potential employee of REGALIA PHARMACEUTICAL (INDIA)

      Purchase full report of REGALIA PHARMACEUTICAL (INDIA)

      Companies are required to file half yearly returns showing payments due to Micro & Small Enterprises that have been delayed more than 45 days. This information is crucial to understand if REGALIA PHARMACEUTICAL (INDIA) pays its vendors promptly. When seen over a period of time, this information could show if the company has slowed down in making payments to its small vendors. This information is available only if the company has filed its half yearly returns with the registrar of companies.

      Filing Type As On Amount Due to MSME Current Liabilities Ratio to Current Liabilities Reasons for Delay

      This section contains details of investor complaints or serious complaints filed with the registrar of companies. This information can surface potential red flags about a company.

      Director Complaints
      Date DIN Cessation Date Cessation Reason Complaint
      Serious Complaints
      Date Complaint Other Details
      Investor Complaints & Other Complaints
      Date Complaint Type Complaint Sub Type Particulars of Secutiries Period Complaint Other Details

      Current Directors & Key Managerial Personnel of REGALIA PHARMACEUTICAL (INDIA)
      DIN Director Name Designation Appointment Date
      01796490 ROHIT DINANATH KARPE Director 2007-10-20
      02828008 ANIL POPATRAO BELKAR Additional Director 2023-08-25
      Past Directors & Key Managerial Personnel of REGALIA PHARMACEUTICAL (INDIA)
      DIN Director Name Designation Appointment Date Cessation
      01796493 SANJAY BHASKAR PANDHARE Director - 2011-10-01
      03485883 SAMEER BHASKAR GODBOLE Director - 2017-08-18
      05154120 SHEETAL PRAKASH BHANDARI Director - 2023-03-31
      06715966 HITESH POPATLAL OSWAL Director - 2023-03-31
      07017813 SATISH SHANKARRAO GADEWAR Director - 2023-03-31
      Other Directorships of ROHIT DINANATH KARPE
      Company Name CIN Designation Appointment Date Cessation
      R. K. HOSPI-MEDISERVICES LLP AAB-1743 Designated Partner 2012-10-19 Ongoing
      AVIRAS REMEDIES LLP AAD-5138 Designated Partner - 2018-11-24
      SPL INFUSION PRIVATE LIMITED U21001MH2024PTC419970 Director 2024-02-26 Ongoing
      REGALIA LIFE SCIENCE PRIVATE LIMITED U24239PN2011PTC139705 Director 2011-06-01 Ongoing
      ROHIT-PHARMA DISTRIBUTORS PRIVATE LIMITED U24290PN2022PTC212049 Director 2022-06-14 Ongoing
      REGALIA LIFE SCIENCE PRIVATE LIMITED U24299PN2020PTC194209 Director 2020-09-19 Ongoing
      DE RIO HEALTHCARE PRIVATE LIMITED U24302PN2020PTC191566 Director 2020-06-29 Ongoing
      REFLECTION IMAGING & DIAGNOSTIC PRIVATE LIMITED U33120PN2011PTC139455 Director 2011-05-06 Ongoing
      JSU PHARMACEUTICAL PRIVATE LIMITED U46497PN2023PTC222802 Director 2023-08-01 Ongoing
      INSAAS SOFTWARE PRIVATE LIMITED U72900PN2012PTC144788 Director - 2014-01-08
      HARINARAYAN LIFESCIENCES PRIVATE LIMITED U74900PN2010PTC138080 Additional Director - 2012-09-29
      HARINARAYAN LIFESCIENCES PRIVATE LIMITED U74900PN2010PTC138080 Director - 2015-01-22
      SYS LOGIC OUTSOURCING PRIVATE LIMITED U74999PN2011PTC139466 Director - 2013-05-18
      ORANGE CHEMISTS PRIVATE LIMITED U74999PN2016PTC166602 Additional Director 2018-08-13 Ongoing
      Other Directorships of SANJAY BHASKAR PANDHARE
      Company Name CIN Designation Appointment Date Cessation
      KRSNAA DIAGNOSTICS LIMITED L74900PN2010PLC138068 Additional Director - 2014-09-30
      KRSNAA DIAGNOSTICS LIMITED L74900PN2010PLC138068 Director - 2019-01-31
      STERITEC BIOSCIENCES PRIVATE LIMITED U24236PN2010PTC135755 Director 2010-03-11 Ongoing
      VET BIOCHEM PRIVATE LIMITED U24240PN2013PTC146134 Director 2013-01-31 Ongoing
      CNP ENGINEERING PRIVATE LIMITED U29299PN2009PTC134070 Additional Director - 2011-02-22
      HARINARAYAN LIFESCIENCES PRIVATE LIMITED U74900PN2010PTC138080 Additional Director - 2012-09-29
      HARINARAYAN LIFESCIENCES PRIVATE LIMITED U74900PN2010PTC138080 Director - 2018-03-23
      Other Directorships of ANIL POPATRAO BELKAR
      Company Name CIN Designation Appointment Date Cessation
      AVIRAS REMEDIES LLP AAD-5138 Designated Partner - 2018-11-24
      WELLMEND PHARMACEUTICAL PRIVATE LIMITED U21000PN2024PTC231960 Director 2024-06-20 Ongoing
      JSU PHARMACEUTICAL PRIVATE LIMITED U46497PN2023PTC222802 Director 2023-08-01 Ongoing
      DAVA INFOTECH PRIVATE LIMITED U72900PN2000PTC014986 Director 2009-11-16 Ongoing
      GROWEVER HEALTHCARE PRIVATE LIMITED U74999PN2016PTC165243 Director - 2018-09-01
      ORANGE CHEMISTS PRIVATE LIMITED U74999PN2016PTC166602 Director - 2018-08-13
      MANOMAY PHARMACEUTICALS PRIVATE LIMITED U74999PN2018PTC177176 Director 2018-06-13 Ongoing
      Other Directorships of SAMEER BHASKAR GODBOLE
      Company Name CIN Designation Appointment Date Cessation
      GPEX WAREHOUSING AND DISTRIBUTION PRIVATE LIMITED U63030MH2021PTC373043 Director 2022-02-01 Ongoing
      SYS LOGIC OUTSOURCING PRIVATE LIMITED U74999PN2011PTC139466 Director 2011-09-07 Ongoing
      Other Directorships of SHEETAL PRAKASH BHANDARI
      Company Name CIN Designation Appointment Date Cessation
      INOVO HEALTHCARE PRIVATE LIMITED U27900PN2023PTC223347 Director 2023-08-22 Ongoing
      RGB HEALTHCARE PRIVATE LIMITED U51397PN2019PTC184339 Director 2019-05-24 Ongoing
      Other Directorships of HITESH POPATLAL OSWAL
      Company Name CIN Designation Appointment Date Cessation
      MANTRA GENERICS AND SURGICAL LLP ACB-5516 Partner - 2024-02-17
      ZENLABS ETHICA LIMITED L74900CH1993PLC033112 Additional Director - 2023-09-30
      PREET REMEDIES LIMITED U24230CH2005PLC027954 Additional Director - 2020-12-16
      PREET REMEDIES LIMITED U24230CH2005PLC027954 Director 2020-12-16 Ongoing
      QUIXOTIC PHARMA PRIVATE LIMITED U24232PB2002PTC025609 Additional Director - 2018-09-30
      QUIXOTIC PHARMA PRIVATE LIMITED U24232PB2002PTC025609 Director 2018-09-30 Ongoing
      GARRON LABS PRIVATE LIMITED U51909PN2013PTC147604 Additional Director - 2015-09-30
      GARRON LABS PRIVATE LIMITED U51909PN2013PTC147604 Director - 2020-11-26
      SHUBH MEDICORP (INDIA) PRIVATE LIMITED U74999PN2013PTC149470 Director 2013-11-19 Ongoing
      Other Directorships of SATISH SHANKARRAO GADEWAR
      Company Name CIN Designation Appointment Date Cessation
      GADEWAR VENTURES LLP AAF-9879 Designated Partner 2016-03-18 Ongoing
      SYNERGIA FOODS LLP AAJ-1788 Designated Partner 2017-12-20 Ongoing
      SYNERGIA FOODS LLP AAJ-1788 Designated Partner - 2017-12-20
      TRANS PHARMACEUTICALS PRIVATE LIMITED U24112PN2010PTC136897 Director 2015-09-21 Ongoing
      SATVIX INFORMATICS PRIVATE LIMITED U72900PN2016PTC158819 Director 2016-03-14 Ongoing
      CURETIC BIOTECHS PRIVATE LIMITED U74900PN2014PTC153289 Director - 2016-08-17

      CIN Company Name Company Address
      View all companies with similar address

      Charge ID Charge Creation Date Charge Modification Date Charge Closure Date Assets Under Charge Amount Charge Holder
      100038767 2016-07-08 - - 2,000,000.00 Indian Bank

      • Email ID
      • Website
      • Address

      This information shows products and services that contribute highest to the company's revenue. Analysing this over a period of time can show the evolution of the company in terms of the products and services it offers.

      Financial Year Business Activity Code Business Activity Description Percentage of Turnover

      Financial information is availalbe only if it has been filed by the company. If the company has not filed its returns, financials for the defaulting period will not be available.

      2024-03-31 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31 2017-03-31 2016-03-31 2015-03-31 2014-03-31 2013-03-31 2012-03-31
      Download Audited Financials
      EQUITY AND LIABILITIES
         Shareholder's funds
            Share Capital
            Reserves & Surplus
            Money Received Against Share Warrants
         Share Application Money Pending Allotment
         Non-current Liabilities
            Long-term borrowings
            Deferred tax liabilities
            Other Long Term Liabilities
            Long Term Provisions
         Current Liabilities
            Short-term borrowings
            Trade Payables
            Other Current Liabilities
            Short Term Provisions
      Total Equity and Liabilities
      ASSETS
         Non-current Assets
            Fixed Assets
               Tangible Assets
               Intangible Assets
               Capital Work In Progress
               Intangible Assets Under Development
            Non-current Investments
            Deferred Tax Assets (net)
            Long-term Loans & Advances
            Other Non-current Assets
         Current Assets
            Current Investments
            Inventories
            Trade receivables
            Cash & Cash Equivalents
            Short-term Loans & Advances
            Other Current Assets
      Total Assets

      Financial information is availalbe only if it has been filed by the company. If the company has not filed its returns, financials for the defaulting period will not be available.

      2024-03-31 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31 2017-03-31 2016-03-31 2015-03-31 2014-03-31 2013-03-31 2012-03-31
      Download Audited Financials
      REVENUE FROM OPERATIONS
         Domestic Turnover
            Sale of Goods Manufactured
            Sale of Goods Traded
            Sale of Supple of Services
         Export Turnover
            Sale of Goods Manufactured
            Sale of Goods Traded
            Sale or Supply of Services
         Other Income
      Total Revenue From Operations
      EXPENSES
         Cost of Materials Consumed
         Purchases of Stock in Trade
         Change in Inventories of
            Finished Goods
            Work in Progress
            Stock in Trade
         Employee benefit Expenses
         Managerial Remuneration
         Payment to Auditors
         Insurance Expenses
         Power & Fuel
         Finance Cost
         Depreciation & Amortization Expenses
         Other Expenses
      Total Expenses
      Profit before Exceptional Items, Extraordinary Items and Tax
         Exceptional Items
      Profit before Extraordinary items and Tax
         Extraordinary Items
      Profit before Tax
         Tax Expense
            Current Tax
            Deferred Tax
      Profit/Loss after Tax from Continuing Operations
      Profit/Loss after Tax from Discontinuing Operations
         Tax Expense of Discontinuing Operations
      Total Profit/Loss
      Earnings per Equity Share (EPS) before Extraordinary Items
         Basic
         Diluted
      Earnings per Equity Share (EPS) after Extraordinary Items
         Basic
         Diluted

      This section contains details of cash raised by allocation of equity or debentures. All types of fund raising acitivity is listed here including funding raised through Venture Capital. Attachments would contain further details of the fund raising activity including names of the investors. This information is available only if the company has raised funds through cash allotment of equity or debentures.

      Date of Allotment Securities Alloted Terms Number of Securities Nominal Amount Premium Amount Due & Payable Premium Amount Paid Total Discount Amount to be Paid on Calls (Excluding Premium) Attachments

      This section contains list of associate companies and joint ventures as per the most recently available annual returns. This information would not be available if the company has not filed annual returns at all or it does not have any subsidiaries or joint ventures.

      Company Identifier Name Percentage of Shares Held

      This section contains list of board resolutions reported by the company to the Registrar of Companies.

      Date of Filing Date of Dispatch of Notice Date of Passing Resolution Section (Companies Act 2013) Section (Companies Act 1956) Subject Matter of Resolution Resolution Agreed By Resolution Type Additional Documents

      This section contains auditors of a company over the years. This information is available if the company has filed their annual returns with the Registrar of Companies.

      Financial Year Name of Auditor or Firm PAN of Auditor or Firm Membership Number / Registration Number Name of Auditor Signing Report Membership Number of Auditor Signing Report

      Is this information out of date or is there a discrepancy with the information? Click on the Update Information button below and we will review the information.

      Purchase our hand crafted financial report for $ 9.99